CHECKR SWOT ANALYSIS TEMPLATE RESEARCH B_179 Supplier concentration increases the risk

Supplier concentration increases the risk of price fluctuations and supply disruptions

TORL BioTherapeutics faces high supplier bargaining power due to specialized needs and limited suppliers

Recruiters report 20-50% lower cost-per-applicant

recurring revenue 62% (EUR 214m)

but manufacturing remains a key risk

CHECKR SWOT ANALYSIS TEMPLATE RESEARCH B_179 Supplier concentration increases the riskYour Strategic Toolkit Starts Here Checkr's SWOT snapshot reveals how its tech driven screening, scale advantages, and marketplace reach stack up against regulatory, competition, and data privacy risks; our full SWOT unpacks these with financial context, scenario driven implications, and tactical recommendations purchase the complete, editable report to turn insights into investor ready strategy and execution tools. Strengths 97 percent automation